Literature DB >> 33737752

Spinal astroglial cannabinoid receptors control pathological tremor.

Eva Maria Meier Carlsen1, Sarah Falk1,2, Urszula Skupio3,4, Laurie Robin3,4, Antonio C Pagano Zottola3,4, Giovanni Marsicano3,4, Jean-François Perrier5.   

Abstract

Cannabinoids reduce tremor associated with motor disorders induced by injuries and neurodegenerative disease. Here we show that this effect is mediated by cannabinoid receptors on astrocytes in the ventral horn of the spinal cord, where alternating limb movements are initiated. We first demonstrate that tremor is reduced in a mouse model of essential tremor after intrathecal injection of the cannabinoid analog WIN55,212-2. We investigate the underlying mechanism using electrophysiological recordings in spinal cord slices and show that endocannabinoids released from depolarized interneurons activate astrocytic cannabinoid receptors, causing an increase in intracellular Ca2+, subsequent release of purines and inhibition of excitatory neurotransmission. Finally, we show that the anti-tremor action of WIN55,212-2 in the spinal cords of mice is suppressed after knocking out CB1 receptors in astrocytes. Our data suggest that cannabinoids reduce tremor via their action on spinal astrocytes.

Entities:  

Year:  2021        PMID: 33737752     DOI: 10.1038/s41593-021-00818-4

Source DB:  PubMed          Journal:  Nat Neurosci        ISSN: 1097-6256            Impact factor:   24.884


  41 in total

1.  The perceived effects of smoked cannabis on patients with multiple sclerosis.

Authors:  P Consroe; R Musty; J Rein; W Tillery; R Pertwee
Journal:  Eur Neurol       Date:  1997       Impact factor: 1.710

2.  Post-traumatic tremor.

Authors:  N Biary; L Cleeves; L Findley; W Koller
Journal:  Neurology       Date:  1989-01       Impact factor: 9.910

Review 3.  A practical guide to the differential diagnosis of tremor.

Authors:  Jane E Alty; Peter A Kempster
Journal:  Postgrad Med J       Date:  2011-06-20       Impact factor: 2.401

4.  Effect of cannabinoids on spasticity and ataxia in multiple sclerosis.

Authors:  H M Meinck; P W Schönle; B Conrad
Journal:  J Neurol       Date:  1989-02       Impact factor: 4.849

Review 5.  Consensus statement of the Movement Disorder Society on Tremor. Ad Hoc Scientific Committee.

Authors:  G Deuschl; P Bain; M Brin
Journal:  Mov Disord       Date:  1998       Impact factor: 10.338

Review 6.  Cannabinoids and Tremor Induced by Motor-related Disorders: Friend or Foe?

Authors:  Shokouh Arjmand; Zohreh Vaziri; Mina Behzadi; Hassan Abbassian; Gary J Stephens; Mohammad Shabani
Journal:  Neurotherapeutics       Date:  2015-10       Impact factor: 7.620

Review 7.  Essential tremors: a family of neurodegenerative disorders?

Authors:  Elan D Louis
Journal:  Arch Neurol       Date:  2009-10

8.  Tetrahydrocannabinol for tremor in multiple sclerosis.

Authors:  D B Clifford
Journal:  Ann Neurol       Date:  1983-06       Impact factor: 10.422

Review 9.  Tremor in multiple sclerosis.

Authors:  Marcus Koch; Jop Mostert; Dorothea Heersema; Jacques De Keyser
Journal:  J Neurol       Date:  2007-02-21       Impact factor: 4.849

10.  Prevalence and characteristics of tremor in the NARCOMS multiple sclerosis registry: a cross-sectional survey.

Authors:  John R Rinker; Amber R Salter; Harrison Walker; Amy Amara; William Meador; Gary R Cutter
Journal:  BMJ Open       Date:  2015-01-08       Impact factor: 2.692

View more
  3 in total

Review 1.  Role of astrocytes in rhythmic motor activity.

Authors:  Alexia Montalant; Eva M M Carlsen; Jean-François Perrier
Journal:  Physiol Rep       Date:  2021-09

2.  Contributions of h- and Na+/K+ Pump Currents to the Generation of Episodic and Continuous Rhythmic Activities.

Authors:  Simon A Sharples; Jessica Parker; Alex Vargas; Jonathan J Milla-Cruz; Adam P Lognon; Ning Cheng; Leanne Young; Anchita Shonak; Gennady S Cymbalyuk; Patrick J Whelan
Journal:  Front Cell Neurosci       Date:  2022-02-04       Impact factor: 5.505

Review 3.  Epigenetic Regulation of Cannabinoid-Mediated Attenuation of Inflammation and Its Impact on the Use of Cannabinoids to Treat Autoimmune Diseases.

Authors:  Bryan Latrell Holloman; Mitzi Nagarkatti; Prakash Nagarkatti
Journal:  Int J Mol Sci       Date:  2021-07-07       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.